Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Opioid Regulation Challenges FDA and Manufacturers

New policies and products seek to maintain access to pain medicines while curbing rampant abuse.
Dec 2, 2013

New policies and products seek to maintain access to pain medicines while curbing rampant abuse.

FDA Seeks Metrics to Define Drug Quality

Manufacturing standards are considered key to preventing drug recalls and shortages.
Nov 13, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.

FDA Promotes Personalized Medicine

Nov 8, 2013

FDA Promotes Personalized Medicine

Breakthrough Therapies Raise Manufacturing Issues

Nov 8, 2013

Breakthrough Therapies Raise Manufacturing Issues

Generic Drug Super Office Takes Shape

Nov 8, 2013

Generic Drug Super Office Takes Shape

FDA Moves to Curb Drug Shortages

Nov 8, 2013

FDA Moves to Curb Drug Shortages

Congress Revises Rules for Drug Compounding and Supply-Chain Security

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
Nov 2, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

FDA Updates Foreign Operations

Oct 4, 2013

Budget issues and changing global markets are prompting FDA to revise its growing network of overseas offices.

FDA Seeks Metrics to Define Drug Quality

Manufacturing standards are considered key to preventing drug recalls and shortages.
Oct 2, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here